Scientists discover immune cell networks driving deadly lung disease
Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...
The Scientist5d
New Microscopy Technique Challenges Therapeutic Antibody Classification
A super-resolution microscopy technique offers an unparalleled glimpse into how monoclonal antibodies bind to their targets ...
Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...
BioSpace6d
Gene Editing, Next-Gen Antibodies Key to Unlocking Animal-to-Human Transplants
It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...
Hosted on MSN11mon
Diagonal Therapeutics raises $128m for antibodies discovery
In preclinical models, agonist antibodies of Diagonal demonstrated the ability to hinder and reverse the formation of pathological ... disorders where signalling pathways have been disrupted ...
Medscape12d
A Curious Case of Anti-D Antibody Titer
Passive anti-D immune globulin administered to prevent anti-D antibody formation in RhD-negative women who carry and are exposed to RhD-positive fetal RBCs; once called Rh "sensitization," this is ...
Hosted on MSN3mon
Nucleic acid drug iSN40 shows promise for osteoporosis treatment
While current treatment options, including antibody-based drugs ... "By targeting the TLR9 pathway, iSN40 effectively blocks the formation of osteoclasts, which play a critical role in ...
Xentria Advances XTMAB16 Study in Pulmonary Sarcoidosis with Completed Enrollment and Key Conference Selections
Xentria, a clinical-stage biopharmaceutical company advancing therapies for rare and serious diseases, today announced the successful completion of enrollment in the therapeutic dose-ranging phase of ...